MAP 2.94% 17.5¢ microba life sciences limited

Ann: Next Generation Product Released to Health Professionals, page-2

  1. 4,423 Posts.
    lightbulb Created with Sketch. 2773
    5 out of 10 to the media bloke for that announcement. Too bland and non-specific, not punchy enough imo. So, what is the use case that will sell this product? Will it be for people overweight that needs to change their microbiome? Will it inform athletes about whether their diets are onpoint? Will the beautiful people see it as the next shiny object? Why would people buy this product? And what are they checking on by running a beta product? They have sold 20,000 of the prior versions of this product. Are they aiming for another 20k at a similar rate or more like 200k?
 
watchlist Created with Sketch. Add MAP (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.